Mutual of America Capital Management LLC Lowers Stock Position in OrthoPediatrics Corp. (NASDAQ:KIDS)

Mutual of America Capital Management LLC cut its position in shares of OrthoPediatrics Corp. (NASDAQ:KIDS) by 4.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 41,130 shares of the company’s stock after selling 1,886 shares during the quarter. Mutual of America Capital Management LLC owned approximately 0.18% of OrthoPediatrics worth $1,337,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in KIDS. RiverPark Advisors LLC bought a new stake in shares of OrthoPediatrics during the 3rd quarter worth $35,000. International Assets Investment Management LLC raised its position in OrthoPediatrics by 3,151.4% in the fourth quarter. International Assets Investment Management LLC now owns 1,203 shares of the company’s stock worth $37,000 after acquiring an additional 1,166 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in OrthoPediatrics by 136.3% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,341 shares of the company’s stock valued at $107,000 after acquiring an additional 1,927 shares during the last quarter. Trust Point Inc. bought a new position in shares of OrthoPediatrics during the 4th quarter valued at approximately $216,000. Finally, Barclays PLC increased its stake in shares of OrthoPediatrics by 48.1% during the 3rd quarter. Barclays PLC now owns 9,284 shares of the company’s stock worth $298,000 after purchasing an additional 3,016 shares during the last quarter. 69.05% of the stock is owned by institutional investors.

Insider Activity

In other news, insider Joseph W. Hauser sold 2,903 shares of the company’s stock in a transaction on Thursday, February 22nd. The shares were sold at an average price of $28.06, for a total value of $81,458.18. Following the transaction, the insider now owns 52,858 shares of the company’s stock, valued at $1,483,195.48. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. In other news, insider Joseph W. Hauser sold 2,903 shares of the business’s stock in a transaction dated Thursday, February 22nd. The stock was sold at an average price of $28.06, for a total transaction of $81,458.18. Following the completion of the transaction, the insider now owns 52,858 shares of the company’s stock, valued at $1,483,195.48. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Fred Hite sold 3,195 shares of the firm’s stock in a transaction that occurred on Monday, March 11th. The shares were sold at an average price of $27.59, for a total transaction of $88,150.05. Following the completion of the sale, the chief financial officer now directly owns 94,072 shares in the company, valued at $2,595,446.48. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 17,253 shares of company stock worth $477,375. 31.80% of the stock is owned by company insiders.

OrthoPediatrics Trading Down 0.4 %

Shares of KIDS stock opened at $30.20 on Tuesday. OrthoPediatrics Corp. has a 1 year low of $23.10 and a 1 year high of $53.50. The company’s fifty day simple moving average is $28.18 and its two-hundred day simple moving average is $28.63. The company has a debt-to-equity ratio of 0.03, a current ratio of 5.44 and a quick ratio of 2.90. The stock has a market capitalization of $718.46 million, a price-to-earnings ratio of -32.83 and a beta of 1.16.

OrthoPediatrics (NASDAQ:KIDS) last issued its quarterly earnings data on Wednesday, March 6th. The company reported ($0.23) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.28) by $0.05. The business had revenue of $37.61 million for the quarter, compared to analysts’ expectations of $37.59 million. OrthoPediatrics had a negative return on equity of 5.03% and a negative net margin of 14.10%. As a group, analysts anticipate that OrthoPediatrics Corp. will post -1.34 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on KIDS shares. JMP Securities reissued a “market outperform” rating and set a $50.00 price objective on shares of OrthoPediatrics in a report on Thursday, March 7th. Truist Financial lowered OrthoPediatrics from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $39.00 to $31.00 in a report on Thursday, January 25th. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $37.00 price objective on shares of OrthoPediatrics in a report on Wednesday, April 10th.

OrthoPediatrics Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.